Partnered Podcast

As the immuno-oncology landscape evolves, developers are facing new challenges in early-phase design, differentiation, and regulatory alignment — all while advancing increasingly complex modalities.

As in vivo CAR-T therapy nears clinical use, researchers and industry leaders explore how it could transform autoimmune disease treatment. Novotech’s Pete Robinson joins Citeline’s Meredith Landry to discuss the science, strategy, and partnerships shaping the future of cell therapy.

As in vivo CAR-T therapy nears clinical use, researchers and industry leaders explore how it could transform autoimmune disease treatment. Novotech’s Pete Robinson joins Citeline’s Meredith Landry to discuss the science, strategy, and partnerships shaping the future of cell therapy.

Hear experts Matthieu Culié and Alessandro Agosti as they discuss how Olon stands out in a competitive landscape through its fully integrated end-to-end ADC manufacturing expertise, global operations, impurity control and strategic facilities.

Listen now as Citeline speaks with Anil Okay, CEO of Europe’s fast-growing pharma B2B, Adalvo. Learn what the company’s recent acquisition by private equity firm EQT means for both Adalvo and for the industry at large, and find out what trends will be fueling pharma in the years ahead.

Listen now as Citeline speaks with top executives from Perceptive to understand eClinical’s major reset and what it means for the future of clinical trials. Learn more about IRT’s evolving role, lessons learned, and how tech will rule the data-driven trials of the future.

In this podcast, ICROM CEO Pierfrancesco Morosini and HOLODIAG GM Pierric Marchand explore innovation in HPAPIs, crystallization science, and what it takes to stand out as a modern CDMO.

Community based trials are reshaping clinical research, broadening patient access and accelerating timelines. Discover the drivers, challenges and future outlook.

Insights from Novotech on Evolving Trends Impacting Global Clinical Development

Insights from Novotech on Evolving Trends Impacting Global Clinical Development

Discover the latest trends in RNA-based therapeutics and learn how sponsors can successfully navigate the road to next generation innovation. Listen in as Citeline chats with the Director of Therapeutics at Novotech, a CRO experienced in RNA development.

Insights from Novotech on Evolving Trends Impacting Global Clinical Development